United Therapeutics (UTHR) Change in Account Payables (2009 - 2013)
United Therapeutics (UTHR) posted Change in Account Payables of -$899000.0 for Q2 2013, down 855.46% sequentially from $119000.0 in Q1 2013, and down 313.03% YoY from $422000.0 in Q2 2012.
United Therapeutics (UTHR) Change in Account Payables (2009 - 2013) Analysis & Trends
United Therapeutics has reported Change in Account Payables for 5 years, with the latest figure at -$899000.0 in Q2 2013.
- Quarterly Change in Account Payables fell 313.03% year-over-year to -$899000.0 in Q2 2013, while the trailing twelve-month figure through Jun 2013 was $562000.0 (up 102.47% YoY) and the FY2012 annual result came in at -$37.2 million, down 323.38% from the prior year.
- Change in Account Payables fell to -$899000.0 in Q2 2013 per UTHR's latest filing, from $119000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $15.6 million in Q4 2011 and troughed at -$39.0 million in Q1 2012.
- A 5-year average of -$1.1 million and a median of $285500.0 in 2011 frame the typical range for Change in Account Payables.
- The widest YoY moves for Change in Account Payables: up 788.59% in 2012, down 533.67% in 2012.
- Over 5 years, Change in Account Payables stood at -$922000.0 in 2009, then soared by 611.61% to $4.7 million in 2010, then jumped by 231.06% to $15.6 million in 2011, then tumbled by 99.88% to $18000.0 in 2012, then sank by 5094.44% to -$899000.0 in 2013.
- According to Business Quant data, Change in Account Payables over the past three periods registered -$899000.0, $119000.0, and $18000.0 for Q2 2013, Q1 2013, and Q4 2012 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Alkermes | 8.14 Bn | 7.48 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2013 | -899,000.00 |
| Jun 30, 2013 | -899,000.00 |
| Mar 31, 2013 | 119,000.00 |
| Mar 31, 2013 | 119,000.00 |
| Dec 31, 2012 | 18,000.00 |
| Dec 31, 2012 | 18,000.00 |
| Sep 30, 2012 | 1.32 Mn |
| Sep 30, 2012 | 1.32 Mn |
| Jun 30, 2012 | 422,000.00 |
| Jun 30, 2012 | 422,000.00 |
| Mar 31, 2012 | -38.97 Mn |
| Mar 31, 2012 | -38.97 Mn |
| Dec 31, 2011 | 15.62 Mn |
| Dec 31, 2011 | 15.62 Mn |
| Sep 30, 2011 | 149,000.00 |
| Sep 30, 2011 | 149,000.00 |
| Jun 30, 2011 | 7.04 Mn |
| Jun 30, 2011 | 7.04 Mn |
| Mar 31, 2011 | -6.15 Mn |
| Mar 31, 2011 | -6.15 Mn |